Thiogenesis Therapeutics, Corp. (TSXV:TTI)
0.500
0.00 (0.00%)
Mar 9, 2026, 2:21 PM EST
-16.67% (1Y)
| Market Cap | 25.92M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -6.82M |
| Shares Out | 51.84M |
| EPS (ttm) | -0.14 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 45,000 |
| Average Volume | 21,485 |
| Open | 0.500 |
| Previous Close | 0.500 |
| Day's Range | 0.500 - 0.500 |
| 52-Week Range | 0.500 - 0.880 |
| Beta | 0.46 |
| RSI | 28.69 |
| Earnings Date | Apr 24, 2026 |